Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 45 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8563039

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Anika Therapeutics S.r.l. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  2. US 8552147

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  3. US 8551936

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  4. US 8546554

    Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  5. US 8546364

    Stabilized steroid composition and method for its preparation

    Precision Dermatology, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  6. US 8546143

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  7. US 8540997

    Complement receptor 1 and 2 fusion proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  8. US 8541373

    BChE albumin fusions for the treatment of cocaine abuse

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  9. US 8535667

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  10. US 8536132

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  11. US 8524456

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  12. US 8506947

    Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  13. US 8507663

    Compositions and methods for inhibiting expression of CD274/PD-L1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  14. US 8501704

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  15. US 8501191

    FGFR2-IIIb fusion proteins and methods of making them

    Five Prime Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  16. US 8492340

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  17. US 8481511

    Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  18. US 8481038

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  19. US 8481507

    Micro-RNAs that control myosin expression and myofiber identity

    The Board of Regents of the University of Texas System · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  20. US 8481516

    Ciclesonide containing sterile aqueous suspension

    TAKEDA GMBH · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  21. US 8481095

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract

    China Medical University · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  22. US 8470344

    Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  23. US 8470324

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  24. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.